-
-
-
-
-
-
-
Nxera Pharma Receives Approval of QUVIVIQ (daridorexant) 25 and 50 mg in Japan for the Treatment of Insomnia
-
-
-
-
-
-
-
Novaremed Expands its Pipeline of Non-opioid Treatment Candidates for Chronic Pain Indications Through Acquisition of Metys Pharmaceuticals
-
-
-
-
-
-
-
Sosei Heptares Successfully Raises US$200 million in International Offering of New Shares and Convertible Bonds
-
-
-
-
-
-
-
Allergan (AGN), Heptares Therapeutics Enter R&D Collaboration; Includes lzheimer's Disease Treatments
-
-
-
-
-
1,157,987 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

